Medscape The committee looked at 2 disease states — metastatic pancreatic cancer and locally advanced disease — and 2 treatments — FOLFIRONOX (irinotecan, oxaliplatin, leucovorin, and 5-fluorouracil) and gemcitabine . It is recommended that clinical trials ... and more »
PR Newswire (press release) UGT1A1 Genetic Variants and Treatment with Camptosar ( irinotecan ) 3.14. CYP2C9 and VKORC1 Variants and Warfarin Dosing 3.15. Personalized Medicine and HIV Therapy: Moving Beyond HIV Viral Load and Drug Resistance Testing • HLA-B*5701 ... and more »
OncLive In a non-symptomatic patient, Grothey would administer a sequence of FOLFIRI and bevacizumab, followed by irinotecan plus cetuximab, and finally regorafenib in the salvage setting. Moving across the panel, Marshall presents the case study to Johanna ... and more »
Wall Street Journal (press release) Additionally, the poster presentation entitled "Phase II clinical activity and tolerability of the SMAC-mimetic birinapant (TL32711) plus irinotecan in irinotecan -relapsed/refractory metastatic colorectal cancer" (Abstract 3621) reported clinical ... and more »
The Oncology Report CHICAGO – The combination of bevacizumab and irinotecan far outshone tenozolomide in delaying disease progression among patients with MGMT-unmethylated glioblastoma, an investigator reported at the annual meeting of the American Society of ...
The Oncology Report CHICAGO – The combination of bevacizumab and irinotecan far outshone tenozolomide in delaying disease progression among patients with MGMT-unmethylated glioblastoma, an investigator reported at the annual meeting of the American Society of ...
OncLive The publication of the OCEANS trial resulted in an addition to the guidelines of the regimen of carboplatin/ gemcitabine / bevacizumab to the list of acceptable recurrence therapies. We'll have more clarity next year when the results of the AURELIA trial ...
The Herald | HeraldOnline.com Historically, drugs have been developed on a "one-size-fits-all" basis, but due to patients responding differently to the same drug and having potentially life threatening side effects, new therapies have been developed for approaching the treatment of ... and more »
Cancer Network CHICAGO—About a decade ago, it was discovered that bevacizumab (Avastin) added to irinotecan (Camptosar) dramatically pruned tumor vessels and reduced vascular permeability in patients with recurrent glioblastoma, as well as significantly improved ...
The Oncology Report CHICAGO – The combination of bevacizumab and irinotecan far outshone tenozolomide in delaying disease progression among patients with MGMT-unmethylated glioblastoma, an investigator reported at the annual meeting of the American Society of ...
